LSB ysbiopharm.com: מדד נזילות מהירה

This chart of LakeShore Biopharma Co. (LSB) asset value on the GURU.Markets platform demonstrates a liquidity ratio of 0.00. The business is currently suffering from US-China trade wars, which are hindering global pharmaceutical exports. Meanwhile, its leadership status in the anti-rabies drug segment guarantees a steady cash flow. Growth is supported by close ties with PRC government centers and the centralized procurement system.

The quick ratio measures a company's ability to settle short-term debts using cash and accounts receivable, intentionally excluding less liquid inventory. By analyzing this quick ratio chart, an investor assesses the financial autonomy of LakeShore Biopharma Co. (LSB), where business model resilience is driven by the diversification of biohubs and strict cold chain control during vaccine deliveries.